This disorganized tumor vasculature also inhibits the effective delivery of immunotherapeutic agents and other drugs to tumor areas and prevents the infiltration of cytotoxic CD8+ T cells, hence supporting cancer cells survival and progression with limited sensitivity to therapeutics (19). This evidence concerns the gene CD8A and cancer.